With multiple drugmakers already announcing a slew of radiopharmaceutical moves this year, France’s Orano Med is doubling ...
A key reason positions haven't been filled is that they require travel that ranges from 25% to 75% of the time.
After a protracted rough patch—which has included layoffs, partnership terminations and lawsuits—San Francisco’s Nektar ...
The factory was manufacturing the suspected culprit ... help them determine the cause of the deaths. Kobayashi Pharmaceutical also has a plant in Wakayama Prefecture where the benikoji ingredient ...
AptarGroup Inc, a firm involved in drug and consumer product dosing, dispensing and protection technologies, held the ...
The company is also raising its full-year guidance to $14.9 billion in adjusted EBITDA, an 8.8% increase from its last ...
The website you are visiting is protected and accelerated by Incapsula. Your computer may have been infected by malware and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback